PRENSKY ZACHARY sold LBRX
September 10, 2025 · Form 4 insider transaction
PRENSKY ZACHARY sold 1,255 shares of LB Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The transactions reported herein reflect a one-time stock option repricing, effective on September 10, 2025, which reduced the per share exercise price of each repriced option to $15, representing the initial public offering price of the Issuer's common stock (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the repriced options, including, without limitation, any provisions with respect to vesting, remain in full force and effect.; Immediately exercisable.